Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

Faculty of 1000 evaluation for Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718003052.793477487 ◽

2013 ◽

Author(s):

Phillip Lieberman

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial

The Laryngoscope ◽

10.1002/lary.23935 ◽

2013 ◽

Vol 123 (6) ◽

pp. 1334-1340 ◽

Cited By ~ 40

Author(s):

De-Hui Wang ◽

Lei Chen ◽

Lei Cheng ◽

Ke-Nan Li ◽

Hu Yuan ◽

...

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2020.07.036 ◽

2020 ◽

Cited By ~ 1

Author(s):

Pascal Demoly ◽

Jonathan Corren ◽

Peter Creticos ◽

Frédéric De Blay ◽

Philippe Gevaert ◽

...

Keyword(s):

Clinical Trial ◽

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Sublingual Tablet ◽

Double Blind Placebo ◽

Phase Iii Clinical Trial ◽

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2014.03.019 ◽

2014 ◽

Vol 134 (3) ◽

pp. 568-575.e7 ◽

Cited By ~ 151

Author(s):

Holger Mosbech ◽

Regina Deckelmann ◽

Fréderic de Blay ◽

Elide Anna Pastorello ◽

Ewa Trebas-Pietras ◽

...

Keyword(s):

Asthma Control ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Inhaled Corticosteroid ◽

Double Blind ◽

Double Blind Placebo ◽

Clinical efficacy and safety of combined house dust mite subcutaneous immunotherapy and omalizumab in five cases of allergic rhinitis and asthma

Indian Journal of Medical Specialities ◽

10.4103/injms.injms_7_21 ◽

2021 ◽

Vol 12 (3) ◽

pp. 175

Author(s):

PC Kathuria ◽

Manisha Rai

Keyword(s):

Allergic Rhinitis ◽

Clinical Efficacy ◽

House Dust ◽

House Dust Mite ◽

Subcutaneous Immunotherapy ◽

Efficacy And Safety ◽

House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis

Clinical & Experimental Allergy ◽

10.1111/cea.12039 ◽

2013 ◽

Vol 43 (2) ◽

pp. 242-248 ◽

Cited By ~ 64

Author(s):

A. Bozek ◽

B. Ignasiak ◽

B. Filipowska ◽

J. Jarzab

Keyword(s):

Allergic Rhinitis ◽

Elderly Patients ◽

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

A randomized, double-blind, placebo-controlled study of Ten-Cha (Rubus suavissimus) on house dust mite allergic rhinitis

Auris Nasus Larynx ◽

10.1016/j.anl.2010.11.017 ◽

2011 ◽

Vol 38 (5) ◽

pp. 600-607 ◽

Cited By ~ 8

Author(s):

Syuji Yonekura ◽

Yoshitaka Okamoto ◽

Kazuki Yamasaki ◽

Shigetoshi Horiguchi ◽

Toyoyuki Hanazawa ◽

...

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2015.06.036 ◽

2016 ◽

Vol 137 (2) ◽

pp. 444-451.e8 ◽

Cited By ~ 122

Author(s):

Pascal Demoly ◽

Waltraud Emminger ◽

Dorte Rehm ◽

Vibeke Backer ◽

Lene Tommerup ◽

...

Keyword(s):

Allergic Rhinitis ◽

Effective Treatment ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Efficacy and safety of the SQ house dust mite (HDM) sublingual immunotherapy-tablet in Japanese children with perennial allergic rhinitis: A randomised, double-blind, placebo-controlled phase 3 trial

10.26226/morressier.5acdc661d462b8029238d85f ◽

2018 ◽

Author(s):

Hendrik Nolte

Keyword(s):

Allergic Rhinitis ◽

House Dust Mite ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Japanese Children ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725732326.793549421 ◽

2018 ◽

Author(s):

Harold Nelson

Keyword(s):

Allergic Rhinitis ◽

Effective Treatment ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽